Active Shortage

APO-CEFEPIME

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of APO-CEFEPIME in Canada?

Yes. APO-CEFEPIME 1G has an active shortage reported to Health Canada (last updated October 16, 2026).

Why is APO-CEFEPIME not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will APO-CEFEPIME be available again?

The estimated resolution date (October 23, 2026) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file2 products

Affected strength1G

Report last updated2026-10-16

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CEFEPIME FOR INJECTION USP

HIKMA CANADA LIMITED

2G · DIN 02499096

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

APO-CEFEPIME

APOTEX INC

2G · DIN 02467518

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.

Estimated Resolution

2026-10-23

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02467496

Strength

Dosage Form

POWDER FOR SOLUTION

Route

INTRAVENOUS INTRAMUSCULAR

Active Ingredient

CEFEPIME

Tier

Unrated

Last Updated

2026-10-16

Reason for Shortage

Disruption of the manufacture of the drug.

Source

View original report on healthproductshortages.ca ↗

Past Reports for This Drug

APO-CEFEPIME has 2 shortage/discontinuation reports on file — this is one of them.

2026-10-27

Resolved

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244